Abraham, A., Joseph, K., Spratlin, J., Zebak, S., Alba, V., Iafolla, M., Ghosh, S., Abdelaziz, Z., Lui, A., Paulson, K., Bedard, E., Chua, N., Tankel, K., Koski, S., Scarfe, A., Severin, D., Zhu, X., King, K., Easaw, J., & Mulder, K. (2022). does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?. Clinical oncology, 34(9), e369–e376. http://access.bl.uk/ark:/81055/vdc_100163065389.0x000026